Housing  Mr. Speaker, I rise today to bring to the attention of the House an issue of monumental concern to my constituents, and indeed to all residents of the Lower Mainland of British Columbia: the crisis in housing. An entire generation of young people is unable to fulfill the dream of owning a home, seniors and families of all types cannot find appropriate housing at a reasonable cost, and renters are being priced right out of Vancouver.

Business of Supply  Mr. Speaker, I have a lot of respect for my hon. colleague. I served on the trade committee with him, and I thank him for his measured speeches. However, in listening to the speeches of his colleagues from the Conservative Party, they have been uniquely confusing. They talk about the need to have pan-Canadian co-operation and to not be divisive.

Business of Supply  Madam Speaker, listening to the Conservatives, it is flabbergasting. The net result of 10 years of their government is that they managed to do the impossible. There was a dual failure. They managed to not only gut environmental legislation in this country but also came up with a complete failure in terms of energy projects.

Parliament of Canada Act  moved for leave to introduce Bill C-212, An Act to amend the Parliament of Canada Act (members who cross the floor). Mr. Speaker, I am honoured to stand in the House to introduce a bill that would deal with the issue of floor crossing, with great thanks to the hon. member for Edmonton—Strathcona.

Canada Elections Act  moved for leave to introduce Bill C-213, An Act to amend the Canada Elections Act (voting age). Mr. Speaker, I am honoured to stand in the House to introduce a bill that would widen the franchise of this country by extending the privilege of voting to Canadians aged 16 or over, with great thanks to the member for Cowichan—Malahat—Langford.

Immigration and Refugee Protection Act  moved for leave to introduce Bill C-214, An Act to amend the Immigration and Refugee Protection Act (appeals). Mr. Speaker, I am once again honoured to rise in the House to introduce an act that would amend the Immigration and Refugee Protection Act, to give a right of appeal to people who apply for permanent residence in this country and have that application denied with no substantive right of appeal, with great thanks to the hon. member for Hochelaga for seconding this.

Questions on the Order Paper  With regard to the Federal Tobacco Control Strategy (FTCS) in fiscal year 2014-2015: (a) what was the budget for the FTCS; (b) how much of that budget was spent within the fiscal year; (c) how much was spent on each of the following components of the FTCS, (i) mass media, (ii) policy and regulatory development, (iii) research, (iv) surveillance, (v) enforcement, (vi) grants and contributions, (vii) programs for Aboriginals of Canada; and (d) were any other activities not listed in (c) funded by the FTCS and, if so, how much was spent on each of these activities?

Questions on the Order Paper  With regard to thalidomide: (a) how many tax-free pensions are being awarded at the level of (i) $100 000, (ii) $75 000 (iii) $25 000; (b) how many recipients have asked for a reassessment of their benefit level, in total, and broken down by (i) applications approved, (ii) applications denied; (c) how many applications have been received for assistance from the Extraordinary Medical Assistance Fund, in total, and broken down by (i) applications approved, (ii) applications denied; (d) what are the criteria for receiving assistance from the Extraordinary Medical Assistance Fund; (e) who is responsible for administering the Extraordinary Medical Assistance Fund; (f) how many new individuals have identified themselves as thalidomide survivors; and (g) how many new individuals have been accepted as thalidomide survivors and will begin receiving support payments?

Questions on the Order Paper  With regard to Health Canada: for the last ten years, (a) how many pharmaceutical manufacturing companies inspected in Canada have received a “proposal to suspend” letter, broken down by year; (b) how many pharmaceutical manufacturing companies inspected in Canada have received an “immediate suspension”, broken down by year; (c) how many pharmaceutical manufacturing companies inspected in Canada that were not sent a proposal to suspend letter or were not subject to a suspension has Health Canada worked with following an inspection to bring about compliance, broken down by year; (d) how many pharmaceutical manufacturing companies inspected in Canada have been subject to a re-inspection within six months, broken down by year; (e) how many pharmaceutical manufacturing companies inspected internationally have received a “proposal to suspend” letter, broken down by year; (f) how many pharmaceutical manufacturing companies inspected internationally have received an “immediate suspension,” broken down by year; (g) how many pharmaceutical manufacturing companies inspected internationally that were not sent a proposal to suspend letter or were not subject to a suspension has Health Canada worked with following an inspection to bring about compliance, broken down by year; (h) how many pharmaceutical manufacturing companies inspected internationally have been subject to a re-inspection within six months, broken down by year; (i) how many import alerts has Health Canada issued with regard to non-compliant health products, broken down by year; (j) which companies have been subject to an import alert; (k) how many voluntary quarantine requests has Health Canada issued, broken down by year; (l) which companies have been subject to a voluntary quarantine request; (m) how many “Notice of Intent to Suspend” letters have been issued to clinical trials, broken down by year; (n) how many “immediate suspensions” has Health Canada issued to clinical trials, broken down by year; (o) how many complaints have been received regarding off-label prescriptions of drugs, broken down by year; and (p) how many cases has Health Canada referred to the Public Prosecution Service of Canada for off-label prescriptions of drugs?

Health  Mr. Speaker, today is the release of the Wait Time Alliance's tenth national report card. It shows that progress to reduce wait times for health care is inconsistent across the country. Palliative care, mental health, home care, and long-term spaces are under-resourced, although demand is climbing.

Resumption of debate on Address in Reply  Mr. Speaker, while my hon. colleague from Calgary has already commented on the hon. member's confusion of volume with logic, I would like to turn this to a question of tone. I must say I am disappointed in the tone that permeated the entire speech of my colleague, at a time when his leader is apparently sending a message to Canadians that he wants a spirit of collegiality and co-operation where the opposition is respected.

Resumption of debate on Address in Reply  Mr. Speaker, I would like to congratulate the hon. member on her election and welcome her to the House. As this is my first opportunity to rise in the 42nd Parliament, I would also like to take this opportunity to thank the good people of Vancouver Kingsway for their trust in me, for the third time.

Questions Passed as Orders for Returns  With regard to hydrocarbon spills in Canada’s waters by commercial entities: (a) how many spills of oil, gas, petrochemical products or fossil fuels have been reported in Canada’s oceans, rivers, lakes or other waterways, broken down by year since 2006; and (b) for each reported spill in (a), identify (i) the product spilled, (ii) the volume of the spill, (iii) the location of the spill, (iv) the name of the commercial entity associated with the spill?

Incorporation by Reference in Regulations Act  Mr. Speaker, as the official opposition trade critic, I am most interested in this discussion. There are some very good points being made on both sides of the House. Obviously, trading jurisdictions have a shared interest in making sure that goods and services can flow as freely as possible across borders.

Questions Passed as Orders for Returns  With regard to the federal executive vehicle fleet, broken down by year since 2012: (a) what was the total number of vehicles in the fleet; (b) what was the (i) total cost of procuring vehicles for the fleet, (ii) total cost of the fleet as a whole; (c) what was the total cost of salaries for drivers, including ministerial exempt staff and federal public servants whose primary responsibility consists of driving vehicles in the fleet; (d) what are the models, years and manufacturers of each vehicle in the fleet; and (e) what are the names and positions of each authorized user of a vehicle in the fleet?